CoChat

Sarcomeric perturbations of myosin motors lead to dilated cardiomyopathy in genetically modified MYL2 mice

Open access
Yuan, Chen-Ching, Kazmierczak, Katarzyna, Liang, Jingsheng, Zhou, Zhiqun, Yadav, Sunil, Gomes, Aldrin V., Irving, Thomas C., Szczesna-Cordary, Danuta · 2018 · Proceedings of the National Academy of Sciences

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

Significance: Dilated cardiomyopathy (DCM) is a progressive heart disease with no current cure, often culminating in heart transplantation. Transgenic D94A (aspartic acid-to-alanine) mice carrying a novel DCM-causative mutation in the MYL2 gene, encoding the cardiac myosin regulatory light chain, were created and investigated by echocardiography and invasive hemodynamic and molecular structural and functional assessments. Our data show that hypocontractile myosin motors and structural perturbations at the level of sarcomeres trigger aberrant functional remodeling in D94A hearts and the development of DCM, which closely follows the clinical phenotype. Left ventricular chamber dilation and decreased ejection fraction, observed in D94A hearts, were indicative of systolic dysfunction, a hallmark of DCM. Our study suggests that MYL2 may be considered a therapeutic target for dilated cardiomyopathy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1716925115

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1. (A) Transgene construct with α-MHC promoter for expression of the D94A-RLC mutant (Left) and amino acid sequence of human cardiac RLC UniProtKB P10916 (pI 4.89; molecular mass 18.789 kDa) (Right). HGH, human growth hormone. (B) Relative expression of D94A-RLC in Tg mice. (B, Right) Sample spectra of human (Upper) and mouse (Lower) RLC sequences. (C) Two-dimensional SDS/PAGE and Western blots of ventricular myosin from WT, D94A-L1, and D94A-L2 mouse lines. RLC proteins were visualized with the CT-1 antibody and the myosin essential light chain (ELC) protein (used as a loading control) with the monoclonal ab680 antibody (Abcam). Phosphorylated and nonphosphorylated human (huRLC-WT and huRLC-D94A) and mouse (muRLC) RLC proteins were separated according to their respective molecular masses and pI, and were quantitated using n = 5 or 6 myosin/myofibrillar preparations per line ±SD. No statistical difference in RLC phosphorylation was observed between WT, D94A-L1, and D94A-L2 mice, P > 0.05, using one-way ANOVA.
Fig. 1. (A) Transgene construct with α-MHC promoter for expression of the D94A-RLC mutant (Left) and amino acid sequence of human cardiac RLC UniProtKB P10916 (pI 4.89; molecular mass 18.789 kDa) (Right). HGH, human growth hormone. (B) Relative expression of D94A-RLC in Tg mice. (B, Right) Sample spectra of human (Upper) and mouse (Lower) RLC sequences. (C) Two-dimensional SDS/PAGE and Western blots of ventricular myosin from WT, D94A-L1, and D94A-L2 mouse lines. RLC proteins were visualized with the CT-1 antibody and the myosin essential light chain (ELC) protein (used as a loading control) with the monoclonal ab680 antibody (Abcam). Phosphorylated and nonphosphorylated human (huRLC-WT and huRLC-D94A) and mouse (muRLC) RLC proteins were separated according to their respective molecular masses and pI, and were quantitated using n = 5 or 6 myosin/myofibrillar preparations per line ±SD. No statistical difference in RLC phosphorylation was observed between WT, D94A-L1, and D94A-L2 mice, P > 0.05, using one-way ANOVA.CC BY-NC-ND · PubMed Central
Fig. 2. (A) Hearts of representative ∼5-mo-old male and female D94A mice and their longitudinal sections showing biventricular cardiac dilation compared with respective WT controls. (Scale bars, 1 mm.) (B) Transmission electron microscopy images of ∼9-mo-old D94A-L1 vs. WT hearts. [Scale bars, 10 µm (Left), 2 µm (Middle), and 1 µm (Right).] Note excessive vacuolar formations in the myocardium of D94A vs. WT mice. (C) Hematoxylin and eosin- and Masson’s trichrome-stained LV sections from ∼5- and ∼12-mo-old M and F D94A-L1 and -L2 vs. WT mice. (Scale bar, 100 µm.) (D) Hydroxyproline content in the hearts of 7- to 11-mo-old M and F D94A-L1 and -L2 compared with WT mice.
Fig. 2. (A) Hearts of representative ∼5-mo-old male and female D94A mice and their longitudinal sections showing biventricular cardiac dilation compared with respective WT controls. (Scale bars, 1 mm.) (B) Transmission electron microscopy images of ∼9-mo-old D94A-L1 vs. WT hearts. [Scale bars, 10 µm (Left), 2 µm (Middle), and 1 µm (Right).] Note excessive vacuolar formations in the myocardium of D94A vs. WT mice. (C) Hematoxylin and eosin- and Masson’s trichrome-stained LV sections from ∼5- and ∼12-mo-old M and F D94A-L1 and -L2 vs. WT mice. (Scale bar, 100 µm.) (D) Hydroxyproline content in the hearts of 7- to 11-mo-old M and F D94A-L1 and -L2 compared with WT mice.CC BY-NC-ND · PubMed Central
Fig. 3. In vivo characterization of heart morphology and function in D94A vs. WT lines by echocardiography (A) and invasive hemodynamics (B). Two lines of D94A (L1 and L2) female (open symbols) and male (closed symbols) were used and the results were compared with age- and sex-matched WT mice. CO, cardiac output; Ea, arterial elastance; EDV, end-diastolic volume; Ees, end-systolic elastance; EF, ejection fraction; FS, fractional shortening; LVID, left ventricular inner diameter in diastole (d) and systole (s); PRSW, prerecruitable SW; SW, stroke work; Tau, relaxation time constant. The number of F and M mice examined is given in Table 1. Data are the mean ± SEM. *P < 0.05, **P < 0.01, and ***P < 0.001 D94A vs. WT, #P < 0.05, and ##P < 0.01 L1 vs. L2, by one-way ANOVA and the post hoc Tukey’s multiple comparison test.
Fig. 3. In vivo characterization of heart morphology and function in D94A vs. WT lines by echocardiography (A) and invasive hemodynamics (B). Two lines of D94A (L1 and L2) female (open symbols) and male (closed symbols) were used and the results were compared with age- and sex-matched WT mice. CO, cardiac output; Ea, arterial elastance; EDV, end-diastolic volume; Ees, end-systolic elastance; EF, ejection fraction; FS, fractional shortening; LVID, left ventricular inner diameter in diastole (d) and systole (s); PRSW, prerecruitable SW; SW, stroke work; Tau, relaxation time constant. The number of F and M mice examined is given in Table 1. Data are the mean ± SEM. *P < 0.05, **P < 0.01, and ***P < 0.001 D94A vs. WT, #P < 0.05, and ##P < 0.01 L1 vs. L2, by one-way ANOVA and the post hoc Tukey’s multiple comparison test.CC BY-NC-ND · PubMed Central
Fig. 4. (A) Contractile function in papillary muscle fibers from ∼5- and ∼12-mo-old D94A-L1 and -L2 vs. WT mice. Open symbols depict female and closed symbols indicate male animals. (B) The effect of D94A mutation on force and calcium transients in intact papillary muscles. The measurements were performed on intact papillary muscles from 6- to 8-mo-old gender-matched D94A-L1 (five M and three F) and WT (three M and three F) mice. Time (in milliseconds) to depart 50% (t50) from t0 to peak during contraction, and from peak to baseline during relaxation, is characterized by TF-contract and TF-relax (force transients) and TC-contract and TC-relax ([Ca2+] transients). Maximum velocity of force departing from and returning to the baseline during muscle contraction and relaxation is reported as VF-contract and VF-relax (force transients) and VC-contract and VC-relax ([Ca2+] transients). Note a significant (*P < 0.05) decrease in TF-relax in D94A-L1 vs. WT fibers. Results are presented as the average ± SD of n animals with *P < 0.05 and **P ≤ 0.01 for mutant vs. WT and #P < 0.05 for D94A-L1 vs. D94A-L2, using one-way ANOVA (A) or Student’s t test (B). (C) Gene expression profiles in D94A and WT mice. Real-time qPCR was performed on three F (open symbols) and three M (close symbols) D94A-L1 and WT mice, and the results are presented as fold change in transcript expression in D94A vs. WT mice. Data are the mean ± SEM. *P < 0.05, using one-way ANOVA with the Tukey’s multiple comparison test.
Fig. 4. (A) Contractile function in papillary muscle fibers from ∼5- and ∼12-mo-old D94A-L1 and -L2 vs. WT mice. Open symbols depict female and closed symbols indicate male animals. (B) The effect of D94A mutation on force and calcium transients in intact papillary muscles. The measurements were performed on intact papillary muscles from 6- to 8-mo-old gender-matched D94A-L1 (five M and three F) and WT (three M and three F) mice. Time (in milliseconds) to depart 50% (t50) from t0 to peak during contraction, and from peak to baseline during relaxation, is characterized by TF-contract and TF-relax (force transients) and TC-contract and TC-relax ([Ca2+] transients). Maximum velocity of force departing from and returning to the baseline during muscle contraction and relaxation is reported as VF-contract and VF-relax (force transients) and VC-contract and VC-relax ([Ca2+] transients). Note a significant (*P < 0.05) decrease in TF-relax in D94A-L1 vs. WT fibers. Results are presented as the average ± SD of n animals with *P < 0.05 and **P ≤ 0.01 for mutant vs. WT and #P < 0.05 for D94A-L1 vs. D94A-L2, using one-way ANOVA (A) or Student’s t test (B). (C) Gene expression profiles in D94A and WT mice. Real-time qPCR was performed on three F (open symbols) and three M (close symbols) D94A-L1 and WT mice, and the results are presented as fold change in transcript expression in D94A vs. WT mice. Data are the mean ± SEM. *P < 0.05, using one-way ANOVA with the Tukey’s multiple comparison test.CC BY-NC-ND · PubMed Central
Fig. 5. (A) Actin-activated myosin ATPase activity of D94A and WT myosins. A significantly lower Vmax was observed for D94A-L1 (0.57 ± 0.02 s−1; n = 14) and D94A-L2 (0.69 ± 0.03 s−1; n = 6) myosins compared with WT (0.88 ± 0.05 s−1; n = 8). (B) Fluorescence-based binding assays of D94A or WT myosin to pyrene-labeled F-actin in the absence of ATP (rigor). Note a significantly higher binding affinity of D94A-L1 (Kd 4.48 ± 0.67 nM; n = 9) and D94A-L2 myosin (Kd 5.73 ± 0.58 nM; n = 10) vs. WT (Kd 8.31 ± 0.35 nM; n = 10) control. Both assays (A and B) were performed on myosin purified from left and right ventricles of 5- to 8-mo-old F and M D94A and WT mice. Approximately four or five hearts per group were used to generate one batch of myosin, and the assays were repeated with two to four different batches of myosin. No differences between the sexes were noted, and the data from M and F mice were pooled. Data are the mean ± SEM of n experiments with *P < 0.05, **P < 0.01, and ***P < 0.001 calculated, using one-way ANOVA with the Tukey’s multiple comparison test.
Fig. 5. (A) Actin-activated myosin ATPase activity of D94A and WT myosins. A significantly lower Vmax was observed for D94A-L1 (0.57 ± 0.02 s−1; n = 14) and D94A-L2 (0.69 ± 0.03 s−1; n = 6) myosins compared with WT (0.88 ± 0.05 s−1; n = 8). (B) Fluorescence-based binding assays of D94A or WT myosin to pyrene-labeled F-actin in the absence of ATP (rigor). Note a significantly higher binding affinity of D94A-L1 (Kd 4.48 ± 0.67 nM; n = 9) and D94A-L2 myosin (Kd 5.73 ± 0.58 nM; n = 10) vs. WT (Kd 8.31 ± 0.35 nM; n = 10) control. Both assays (A and B) were performed on myosin purified from left and right ventricles of 5- to 8-mo-old F and M D94A and WT mice. Approximately four or five hearts per group were used to generate one batch of myosin, and the assays were repeated with two to four different batches of myosin. No differences between the sexes were noted, and the data from M and F mice were pooled. Data are the mean ± SEM of n experiments with *P < 0.05, **P < 0.01, and ***P < 0.001 calculated, using one-way ANOVA with the Tukey’s multiple comparison test.CC BY-NC-ND · PubMed Central
Fig. 6. Small-angle X-ray diffraction patterns and integrated intensity traces collected from papillary muscles from D94A-L1 (n = 3 F and 3 M mice) vs. WT (n = 4 F and 3 M mice) in relaxation (pCa 8) and activation (pCa 5.2). All patterns show clearly resolved 1,0 and 1,1 reflections. Note the significant difference in I1,1/I1,0 between D94A-L1 and WT (P = 0.043). Data are the mean ± SEM of n animals with *P < 0.05, using Student’s t test.
Fig. 6. Small-angle X-ray diffraction patterns and integrated intensity traces collected from papillary muscles from D94A-L1 (n = 3 F and 3 M mice) vs. WT (n = 4 F and 3 M mice) in relaxation (pCa 8) and activation (pCa 5.2). All patterns show clearly resolved 1,0 and 1,1 reflections. Note the significant difference in I1,1/I1,0 between D94A-L1 and WT (P = 0.043). Data are the mean ± SEM of n animals with *P < 0.05, using Student’s t test.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Cited by

See all 36

Metadata

Authors
Yuan, C.-C., Kazmierczak, K., Liang, J., Zhou, Z., Yadav, S., Gomes, A. V., Irving, T. C., & Szczesna-Cordary, D.
Affiliations
  • University of Miami (US)
  • Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL 33136;
  • University of California, Davis (US)
  • Illinois Institute of Technology (US)
Venue
Proceedings of the National Academy of Sciences
Published
2018-02-20
Volume
115
Issue
10
Pages
E2338-E2347
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2793586929
Cited by
36
References
38
Citations by year
2026: 2 · 2025: 1 · 2024: 6 · 2023: 2 · 2022: 6 · 2021: 7 · 2020: 4 · 2019: 6 · 2018: 2
FWCI
3.59
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by-nc-nd)
Funders
  • HHS | NIH | National Heart, Lung, and Blood Institute (HL123255, HL096819)
  • HHS | NIH | National Institute of General Medical Sciences (9P41-GM103622)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords
dilated cardiomyopathy, myosin light chain 2, systolic dysfunction, left ventricular dilatation, ejection fraction, transgenic mouse model, cardiac remodeling, therapeutic target
MeSH terms
Animals, Cardiomyopathy, Dilated, Disease Models, Animal, Female, Humans, Male, Mice, Transgenic, Myocardial Contraction, Sarcomeres, Myosin Light Chains, Mutation, Missense, Myocytes, Cardiac, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sarcomeric perturbations of myosin motors lead to dilated cardiomyopathy in genetically modified MYL2 mice. https://app.cochat.ai/papers/10.1073/pnas.1716925115
The paper
Yuan, C.-C., Kazmierczak, K., Liang, J., Zhou, Z., Yadav, S., Gomes, A. V., Irving, T. C., & Szczesna-Cordary, D. (2018). Sarcomeric perturbations of myosin motors lead to dilated cardiomyopathy in genetically modified MYL2 mice. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1716925115

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.